Tag Archives: Bristol Myers

Pfizer Inc. (NYSE:PFE) Plans to Buy NextWave Pharmaceuticals in $680 Million Bid – MRK, JNJ, BMY, AMGN, UNH, ABT, LLY, MNKD

Pfizer Inc. (PFE) reported on Monday that it will pay almost $680 million to purchase private company NextWave Pharmaceuticals for approximately $680 million.

The agreement comprises of a payment of $255 million to NextWavestockholders, plus almost $425 million more formed …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off

Abbott Laboratories (ABT) Gets FDA’s Green Signal for Humira – ABT, MRK, SNY, DNDN, BSX, WCRX, PFE, BMY, PPHM

Abbott Laboratories Inc. (NYSE:ABT) reported on Friday that the Food and Drug Administration accepted its drug Humira as a cure for ulcerative colitis in adults.

The FDA accepted Humira as a cure for modest to harsh ulcerative colitis when other …

Posted in Latest Headlines, Services | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off

UnitedHealth Group (UNH) Makes its Way in DJIA, Pushing Out Kraft Foods – UNH, AET, HUM, THC, GILD, SNY, PFE, JNJ, BMY

UnitedHealth Group Inc. (NYSE:UNH) would substitute Kraft Foods Inc. (NYSE:KFT) in the Dow Jones Industrial Average DJIA, the 30-components blue-chip index, in the wake of Kraft’s intention to spin off its North American grocery unit.

On Friday, S&P Dow Jones …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off

Dyax (NASDAQ:DYAX) Stops Clinical Trial of Angioedema Drug Kalbitor – DYAX, VPHM, PDLI, BMY

Dyax Corp (NASDAQ:DYAX) reported on Thursday that the company was discontinuing a clinical experiment of its angioedema medicine Kalbitor as the drug was not working better than a placebo.

Kalbitor is approved as a cure for keen attacks of hereditary …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , | Comments Off

Eli Lilly (NYSE:LLY) Targets Sanofi’s (NYSE:SNY) Top-Seller Lantus on Weight Loss – LLY, SNY, AZN, BMY

Eli Lilly & Co’s (NYSE:LLY) experimental insulin matched Sanofi’s SA (ADR) (NYSE:SNY) top-seller Lantus at controlling blood sugar while assisting patients to drop weight, a verdict that may offer Lilly an edge in the $20 billion diabetes marketplace.

The American …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , | Comments Off

Senate Approves FDA Fee Plan of $6.4 Billion with Eli Lilly (NYSE:LLY) and Medtronic (NYSE:MDT) – LLY, SNY, AZN, BMY

The Food and Drug Administration got United States Senate endorsement for its $6.4 billion fee accord with Eli Lilly & Co (NYSE:LLY), Medtronic, Inc (NYSE:MDT) and other corporations that would fund authoritarian evaluations of new medicines and gadgets through 2017.…

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , | Comments Off